CINDY HOPKINS: Open Payments
NPI 1508426693 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,386 in 64 payments from 23 companies in 2025. Trend: 2023 $16 · 2024 $948 · 2025 $1,386
Food & beverage: $1,386
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $202 |
| Lilly USA, LLC | 10 | $165 |
| Corcept Therapeutics | 4 | $146 |
| ABBVIE INC. | 2 | $144 |
| PFIZER INC. | 7 | $117 |
| GlaxoSmithKline, LLC. | 7 | $114 |
| Axsome Therapeutics, Inc. | 3 | $66 |
| Amgen Inc. | 3 | $45 |
| Phathom Pharmaceuticals, Inc. | 3 | $44 |
| AstraZeneca Pharmaceuticals LP | 3 | $43 |
Products named: Ozempic, Korlym, QULIPTA, JARDIANCE, TRELEGY ELLIPTA, MOUNJARO, Auvelity, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
